The ASK1 dependent activation of p38 and JNK MAPK pathways finally triggered the apoptotic death of AML cells, as evident from a dose-dependent elevation of apoptotic markers such as cleaved PARP and caspase 3 (Fig. 10E). Here, MAP3K5 is linked to acute myeloid leukemia.